Scarica l'app Stockscreener
2.445
0.81%
-0.025
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUMA Giù?
Forum
Previsione
Precedente Chiudi:
$2.47
Aprire:
$2.47
Volume 24 ore:
1.46M
Relative Volume:
0.38
Capitalizzazione di mercato:
$380.04M
Reddito:
-
Utile/perdita netta:
$-110.78M
Rapporto P/E:
-2.285
EPS:
-1.07
Flusso di cassa netto:
$-75.59M
1 W Prestazione:
+6.52%
1M Prestazione:
+15.57%
6M Prestazione:
-46.27%
1 anno Prestazione:
-68.79%
Intervallo 1D:
$2.415
$2.52
Intervallo di 1 settimana:
$2.415
$2.82
Portata 52W:
$1.15
$9.79
Humacyte Inc Stock (HUMA) Company Profile
Nome
Humacyte Inc
Settore
Industria
Telefono
919-313-9633
Indirizzo
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Confronta HUMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
2.45 | 392.45M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.18 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.91 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.46 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.17 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.19 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-20 | Reiterato | H.C. Wainwright | Buy |
| 2023-12-11 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-14 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-05-16 | Downgrade | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | Iniziato | Cowen | Outperform |
| 2021-09-24 | Iniziato | Oppenheimer | Outperform |
| 2021-09-22 | Iniziato | BTIG Research | Buy |
| 2021-09-16 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Humacyte Inc Borsa (HUMA) Ultime notizie
Humacyte, Inc. (NASDAQ:HUMA): Is Breakeven Near? - Yahoo Finance
Why is Humacyte Inc. stock attracting strong analyst attentionBest Dividend Picks For 2025 - jammulinksnews.com
Is Humacyte Inc. a growth stock or a value stockMaximize your returns with smart trade entries - jammulinksnews.com
How does Humacyte Inc. compare to its industry peersMaximize returns with disciplined investment techniques - jammulinksnews.com
When is Humacyte Inc. stock expected to show significant growthAchieve rapid capital gains with smart investing - jammulinksnews.com
What makes Humacyte Inc. stock price move sharplyTriple-digit returns - jammulinksnews.com
Does Humacyte Inc. Equity Warrant stock perform well during market downturnsMaximize portfolio returns with smart trading - jammulinksnews.com
What institutional investors are buying Humacyte Inc. Equity Warrant stockAchieve fast wealth growth with smart picks - jammulinksnews.com
When is Humacyte Inc. Equity Warrant stock expected to show significant growthSkyrocketing investment returns - jammulinksnews.com
What catalysts could drive Humacyte Inc. Equity Warrant stock higher in 2025Unmatched profit potential - jammulinksnews.com
What are Humacyte Inc. company’s key revenue driversInvest confidently with professional market insights - jammulinksnews.com
How does Humacyte Inc. generate profit in a changing economyUnlock exclusive stock market insights - jammulinksnews.com
What institutional investors are buying Humacyte Inc. stockCapitalize on market momentum for maximum profit - jammulinksnews.com
How strong is Humacyte Inc. Equity Warrant company’s balance sheetMassive wealth growth - jammulinksnews.com
Should I hold or sell Humacyte Inc. stock in 2025Capitalize on fast-growing investment opportunities - jammulinksnews.com
Why is Humacyte Inc. Equity Warrant stock attracting strong analyst attentionMaximize your gains with expert trading tips - jammulinksnews.com
Is Humacyte Inc. stock overvalued or undervaluedMaximize your gains with professional insights - jammulinksnews.com
Humacyte Inc. Stock Analysis and ForecastExplosive trading opportunities - PrintWeekIndia
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
What drives Humacyte Inc. stock priceExceptional return forecasts - PrintWeekIndia
Humacyte Inc. Equity Warrant Stock Analysis and ForecastDynamic profit expansion - PrintWeekIndia
What analysts say about Humacyte Inc. Equity Warrant stockOutstanding investment returns - PrintWeekIndia
Will Humacyte Inc. Equity Warrant stock benefit from AI tech trendsBreakout stock performance - jammulinksnews.com
What analysts say about Humacyte Inc. stockExceptional risk-adjusted gains - PrintWeekIndia
Humacyte, Inc. (HUMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Humacyte rises on Symvess sale to military treatment facility - MSN
Would Humacyte (NASDAQ:HUMA) Be Better Off With Less Debt? - 富途牛牛
Humacyte stock rises after first Symvess sale to US Military facility - Investing.com Australia
What drives Humacyte Inc. Equity Warrant stock priceExplosive trading opportunities - Autocar Professional
Humacyte, Inc. shares rise 1.47% after-hours after announcing first Symvess sale to U.S. Military Treatment Facility. - AInvest
Humacyte shares climb 6% after first Symvess sale to U.S. military hospital - MSN
Is Humacyte Inc. Equity Warrant a good long term investmentUnprecedented profit potential - Autocar Professional
Humacyte stock rises after first Symvess sale to US Military facility By Investing.com - Investing.com South Africa
Humacyte Inc Azioni (HUMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.67%
2.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):